In one paragraphArticle in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Florencia Silvina ContiGrupo de Investigaciones Básicas y Aplicadas en Inmunología y Bioactivos (GIBAIB, INEDES-CONICET), Departamento de Ciencias Básicas, Universidad Nacional de Luján (UNLu), Luján C6700, Argentina.ORCID 0009-0009-4713-6179 Exequiel GiorgiGrupo de Investigaciones Básicas y Aplicadas en Inmunología y Bioactivos (GIBAIB, INEDES-CONICET), Departamento de Ciencias Básicas, Universidad Nacional de Luján (UNLu), Luján C6700, Argentina.
Laura MontaldoGrupo de Investigaciones Básicas y Aplicadas en Inmunología y Bioactivos (GIBAIB, INEDES-CONICET), Departamento de Ciencias Básicas, Universidad Nacional de Luján (UNLu), Luján C6700, Argentina.ORCID 0000-0002-0949-9325 Juan Pablo RodríguezLaboratorio de Investigaciones Bioquímicas, Facultad de Medicina (LIBIM), Instituto de Química Básica y Aplicada del Nordeste Argentino (IQUIBA-NEA), Universidad Nacional del Nordeste, Consejo Nacional de Investigaciones Científicas y Técnicas (UNNE-CONICET), Corrientes W3400, Argentina.ORCID 0000-0002-8713-7178 Mauricio Cesar De MarziGrupo de Investigaciones Básicas y Aplicadas en Inmunología y Bioactivos (GIBAIB, INEDES-CONICET), Departamento de Ciencias Básicas, Universidad Nacional de Luján (UNLu), Luján C6700, Argentina.ORCID 0000-0003-3271-9768 Federico Gastón BaudouGrupo de Investigaciones Básicas y Aplicadas en Inmunología y Bioactivos (GIBAIB, INEDES-CONICET), Departamento de Ciencias Básicas, Universidad Nacional de Luján (UNLu), Luján C6700, Argentina.ORCID 0000-0003-1349-3820 Funding
Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación GRF-TI 507Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación PICT 2019-01109National University of Luján IeF 2022-005, SCyT 05/22
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
adjuvantsnanovenomsPLA2serotherapySiNPssnake venom
Identifiers
PMID40733089
PMCPMC12299363
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390